Which antibiotics for mrsa infection

For 37 children, therapy was not changed to an antibiotic to which the pathogen was susceptible, whereas therapy was changed to an appropriate antibiotic for 21 children.

There was no difference in outcome in children who received an appropriate antibiotic compared with children who did not receive an appropriate antibiotic. Of the four children hospitalized on the first follow-up visit, none had received an appropriate antibiotic.

A significant predictor of hospitalization was initial lesion size — children with a lesion more than 5 cm were more likely to be admitted. Receipt of an initial antibiotic to which the CA-MRSA isolate was not susceptible was not a significant predictor of hospitalization. Thus, incision and drainage without adjunctive antibiotic treatment was an effective therapy in children with CA-MRSA skin and soft tissue abscess infection when the lesion was five cm or less.

Other published studies have also concluded that incision and drainage, without antibiotic therapy, can be employed as successful treatment of skin and soft tissue abscess formation, including CA-MRSA infection. Oral antibiotic choices most likely to be used by pediatric clinicians include clindamycin, trimethoprim-sulfamethoxazole, doxycycline, minocycline, rifampin and linezolid.

Data describing the effectiveness of these agents in children with CA-MRSA infection come primarily from observational studies and case reports. Data are not available from controlled trials, and thus more definitive treatment recommendations and guidelines are not currently available. Because TMP-SMX contains a sulfonamide antibiotic, it should not be used in children with a history of a documented true allergic reaction to previous sulfonamide use. As TMP-SMX may displace bilirubin from albumin binding sites, this antibiotic should not be used in newborns with increased bilirubin.

Because TMP-SMX does not provide adequate activity toward group A streptococcus, it should not be used if this pathogen is suspected eg, infection associated with lymphangitis, concomitant streptococcal pharyngitis, erysipelas or is grown upon culture. Clindamycin is another antibiotic frequently recommended as an initial therapeutic option. However, it is important that inducible resistance be tested for when using clindamycin. Resistance may develop rapidly with clindamycin use, despite an initial sensitivity report indicating that the MRSA isolate is susceptible.

Most, if not all, microbiology laboratories can utilize the disk diffusion method D-zone test to test for inducible macrolide-lincosamide-streptogramin B MLS B resistance. Clindamycin should not be used if the D-test is positive, which indicates inducible resistance. Clindamycin is available in liquid formation, although it is not particularly palatable.

Parenthetically, many pharmacies are able to flavor liquid medication products with commercially available flavoring systems. Although MRSA is usually sensitive to vancomycin, strains with intermediate susceptibility, or, more rarely, resistant strains have been reported.

Doxycycline and minocycline have been reported in a small number of adult case reports to be effective therapy for MRSA infection, including skin and soft tissue infections caused by CA-MRSA.

As both of these agents are members of the tetracycline class, they should not be used in children aged younger than 9 years. No data are available for their use in children. Minocycline may rarely cause significant adverse effects. Linezolid Zyvox is a unique antibiotic, a member of the oxazolidinone class. Linezolid provides good in vitro activity toward MRSA, although resistance has been reported.

Patients with MRSA are infected with a strain of Staph aureus bacteria resistant to antibiotics known as beta-lactams, such as methicillin, amoxicillin and penicillin. For a local skin MRSA infection, draining the abscess at the doctor's office is usually the only treatment needed.

Few antibiotics are available to treat more serious MRSA infections. It is important to finish all doses of antibiotics you have been given, even if you feel better before the final dose. Beginning in , there have been a handful of cases documented in which the bacterium was also found to be resistant to one of the last available drugs being used to treat it — vancomycin Vancocin.

Historically, most cases of MRSA infection occurred in the hospital setting, but in , cases began cropping up in community settings among individuals who had not been hospitalized. The first domestic cluster involved a group of IV-drug users in Detroit.

A second cluster of drug users was infected in , and the prevalence of CA-MRSA began to increase in the community at large in the mids. But MRSA is not limited to those sites. It has also been found in other locations, including Washington State beaches and marine water. These infections are typically easier to treat than HA-MRSA infections, but some patients with CA-MRSA develop such serious conditions as necrotizing pneumonia, disseminated invasive osteomyelitis, septic arthritis or endocarditis.

Three different S. MRSA colonization is a risk factor for infection, although the link between colonization and infection needs further investigation. The organism is sometimes found on the skin or carried inside the nose of healthy individuals. People who come into contact with farm animals may also be at greater risk for infection.

And farm animals are not the only ones becoming infected. Rates of MRSA are also up among household pets, such as dogs and cats. While people can contract MRSA infections from many different sources, the most common route to infection remains transmission through direct skin-to-skin contact.